A phase 2 study of trametinib for patients with pediatric...

BMC Cancer 2019 / 12 Vol. 19; Iss. 1

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

Perreault, Sébastien, Larouche, Valérie, Tabori, Uri, Hawkin, Cynthia, Lippé, Sarah, Ellezam, Benjamin, Décarie, Jean-Claude, Théoret, Yves, Métras, Marie-Élaine, Sultan, Serge, Cantin, Édith, Routhie
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-019-6442-2
Date:
December, 2019
File:
PDF, 347 KB
english, 2019
Conversion to is in progress
Conversion to is failed